Showing results (1-10 of 181) with videos related to
Sort By:
Pageof 19
Cancer|February 22, 2002
Severe interstitial pneumonitis associated with docetaxel administrationWilliam L Read, Joanne E Mortimer, Joel PicusCurrent Opinion in Obstetrics & Gynecology|December 19, 2009
Managing the toxicities of the aromatase inhibitorsJoanne E MortimerGeriatrics|September 26, 2002
Hormone replacement therapy and beyond. The clinical challenge of menopausal symptoms in breast cancer survivorsJoanne E MortimerCurrent Urology Reports|April 25, 2006
The role of primary chemotherapy for prostate cancer: has the time come?P Paula Hruska, Joel PicusAmerican Journal of Clinical Oncology|June 1, 2005
Evaluating risk factors for the development of ifosfamide encephalopathyKevin A David, Joel PicusBreast Cancer Research : BCR|October 29, 2003
Positron emitting 18F-2-deoxy-2-fluoro-D-glucose: potential hot new therapyJoanne E Mortimer, Marie E TaylorOncology (Williston Park, N.Y.)|June 13, 2003
Long-term toxicities of selective estrogen-receptor modulators and antiaromatase agentsJoanne E Mortimer, Janice H UrbanSeminars in Oncology|August 5, 2010
Safety considerations for use of bone-targeted agents in patients with cancerJoanne E Mortimer, Sumanta Kumar PalClinical Breast Cancer|October 9, 2007
Patterns of bisphosphonate use in the United States in the treatment of metastatic bone diseaseJoanne E Mortimer, Kathy Schulman, Joseph D KohlesCase Reports in Oncology|April 12, 2016
Metastatic Angiosarcoma with Kasabach-Merritt Syndrome Responsive to Gemcitabine and Vinorelbine after Failure of Liposomal Doxorubicin and Paclitaxel: A Case ReportWilliam L Read, Felicia WilliamsPageof 19